The new findings shed light on how cancer cells found in different parts of a tumour behave differently.
Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales.
Using the technology, scientists have revealed that cell division isn’t necessarily the main cause of genetic changes in human tissue DNA.
Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year.
Reluctance to attend hospital tests and come forward about symptoms could be contributing to delays in lung cancer diagnosis.
Nearly half of people who had potential cancer symptoms in the first wave of the COVID-19 pandemic did not contact their GP.
Health officials are urging people to get symptoms checked, after figures suggest that thousands of people in England could have undiagnosed lung cancer.
Genetic changes in tumours could be used to predict who will benefit from immunotherapy, and who should receive other treatments.
Lymphoma patients in England are among the first in the world to be offered new CAR T cell therapy.